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SI Text
SI Material and Methods. Plasmid construction. All plasmids were
constructed by using standard molecular biology techniques
(1). Plasmid maps are provided in Fig. S8. All oligonucleotides
were synthesized by Integrated DNA Technologies, and all con-
structs were sequence verified (Laragen, Inc.). Cloning enzymes,
including restriction enzymes and T4 DNA ligase, were obtained
from New England Biolabs, and DNA polymerases were ob-
tained from Stratagene.
A fusion of the firefly luciferase (ffluc) gene and the
Sh ble gene encoding zeocin resistance was PCR amplified from
pMOD-LucSh (Invivogen) by using forward and reverse primers
Kozak BamHI5′ (5′ATCGGATCCGCCGCCACCATGGA GG-
ATGCCAAGAATATTAAGAAAGG) and zeocin XbaI3′ (5′
TATTCTAGATCAGT CCTGCTCCTCTGCCACAAAGTGC),
respectively. The plasmid pffLuc:zeo was constructed by inserting
the resulting PCR product into pcDNA3.1(+) (Invitrogen) via
the unique restriction sites BamHI and XbaI located in the multi-
cloning site behind the CMV promoter.
The cd19 gene was PCR amplified from CD19t-Tk-T2A-IL15o-
p_epHIV7 by using forward and reverse primers CD19t BlpI5′ (5′
ATTGCTGAGCCTAGAGCTGAAG) and CD19t-mutsr39TK
FR (5′CCCGCAGTAGCGTGGGCATTCTTTTCCTCCTCAG-
GAC CAG), respectively. The thymidine kinase gene mutsr39tk
was PCR amplified from mutsr39tk_pcDNA3.1(+) by using for-
ward and reverse primers CD19t-mutsr39TK FF (5′C TG-
GTCCTGAGGAGGAAAAGAATGCCCACGCTACTGCGGG)
and mutsr39TK-T2A FR (5′CCTCTCCGCCGCCAGATCTGT-
TAGCCTCCCCCATCTCCC), respectively. The cytokine gene
il-15 was PCR amplified from CD19t-Tk-T2A-IL15op_epHIV7
by using forward and reverse primers mutsr39TK FF (5′GGGA-
GATGGG GGAGGCTAACAGATCTGGCGGCGGAGAGG)
and IL15op BsrGI3′ (5′TCTCGGTG TACAGGGTGGCG), re-
spectively. PCR products for the three genes were assembled
via a fourth PCR reaction by using forward and reverse primers
CD19t BlpI5′ and IL15op BsrGI3′, respectively. The plasmid
pIL15 was constructed by inserting the assembled PCR product
(cd19-mutsr39tk-t2a-il15) into CD19t-Tk-T2A-IL15op_epHIV7
via the unique restriction sites BlpI and BsrGI behind the EF1α
promoter.
The fluorescence gene egfp was PCR amplified from eGFP_
pcDNA3.1(+) by using forward and reverse primers eGFP
KpnI5′ (5′CTTGGTACCCGCCACCATGGTGAGC AAG) and
T2A-IL2 FR (5′CCACGTCACCGCATGTTAGAAGACTTC-
CTCTGCCCTC TCCGCTGCCCTTGTACAGCTCGTCCATG-
CC), respectively. The cytokine gene il-2 was PCR amplified from
IL2_pSK by using forward and reverse primers T2A-IL2 FF (5′
CT TCTAACATGCGGTGACGTGGAGGAGAATCCCGGCC-
CTATGTACAGGATGCAACTCCTGTC) and IL2 XhoI3′ (5′
AGACTCGAGTCAAGTTAGTGTTGAGATGATGC), respec-
tively. PCR products for the two genes were assembled via a third
PCR reaction by using forward and reverse primers eGFP KpnI5′
and IL2 XhoI3′, respectively. The plasmid eGFP-T2A-IL2_pcD-
NA3.1(+) was constructed by inserting the assembled PCR pro-
duct (egfp-t2a-il2) into pcDNA3.1(+) via the unique restriction
sites KpnI and XhoI behind the CMV promoter. A DNA se-
quence including the CMV promoter, the egfp-t2a-il2 fusion gene,
and the poly-A sequence was PCR amplified from eGFP-T2A-
IL2_pcDNA3.1(+) by using forward and reverse primers CMV
HpaI5′ (5′AATAGTTAAC GTTGACATTGATTATTGACTAG-
TTATTAATAGTAATCAA) and bGHpA SacII3′ (5′AATACCG-
CGGCCATAGAGCCCACCGC), respectively. The PCR pro-
duct was inserted into dsRed Express_pcDNA3.1(+) via the un-
ique restriction sites HpaI and SacII. The CMV promoter
regulating the egfp-t2a-il2 fusion gene was replaced by the
EF1α promoter via the unique restriction sites BglII and KpnI
to construct the plasmid pIL2. The EF1α promoter sequence
was PCR amplified from pIL15 by using forward and reverse pri-
mers EF1α BglII5′ (5′AATAGATATCTGCTTCGCGAGGA-
TCTGC) and EF1 α KpnI3′ (5′AATAGGTACCGGTGGCGG-
CGCTAG), respectively.
A standardized cloning method was developed to allow for
the sequential insertion of engineered ribozyme switches and
corresponding control constructs in the 3′ UTR of the target
transgenes. The engineered ribozyme switch constructs were gen-
erated by PCR amplification by using the forward primer Rz
XhoI-AsiSI5′ (5′AATACTCGAG GCGATCGCAAACAAACA-
AA), where the underlined sequences indicate restriction sites
for XhoI and AsiSI, respectively, and the reverse primer Rz
ApaI-PacI3′ (5′AATA GGGCCCAAGATTAATTAAAAAAAA-
AATTTTTATTTTTCTTTTTGCTGTT), where the underlined
sequences indicate restriction sites for ApaI and PacI, respec-
tively. The italicized sequences indicate spacers flanking each ri-
bozyme switch, and the 3′ spacer sequence forms a hairpin
structure consisting of A-U pairs to provide insulation for each
ribozyme switch. The first copy of an engineered ribozyme switch
in each plasmid (using pIL2 or pIL15 as the plasmid backbone)
was inserted via the unique restriction sites XbaI and ApaI. All
subsequent copies of the engineered ribozyme switches were in-
serted behind the 3′ end of the previous copy of ribozyme switch
by digesting the plasmid with PacI and ApaI and the insert with
AsiSI and ApaI, where digestion with PacI and AsiSI results in
identical sticky ends. The resulting ligation product retained
unique PacI and ApaI sites while eliminating the AsiSI site, thus
allowing the cloning strategy to be repeated for each additional
copy of the ribozyme switch inserted into the construct.
Transient transfection and fluorescence quantification. All transient
transfections into CTLL-2 cells were performed with an Amaxa
Nucleofector II and the Mouse T Cell Nucleofector Kit (Amaxa)
following the manufacturer’s protocols. Electroporations were
performed with 2 × 106 cells and 3 μg of plasmid DNA. One hour
after electroporation, samples were diluted 2-fold with supple-
mented RPMI medium 1640 and split into two wells, one treated
with small-molecule input and one without input. In experiments
testing a range of input concentrations, multiple aliquots of cells
were electroporated as described. One hour after electropora-
tion, samples were combined, diluted 2-fold, split into the appro-
priate number of wells, and each treated with the appropriate
concentration of small-molecule input. Fluorescence and cell via-
bility data were obtained 24 and 48 hours after transfection, re-
spectively, by using a Quanta Cell Lab Flow Cytometer (Beckman
Coulter) equipped with a 488-nm laser. EGFP, phycoerythrin
(PE), and dsRed-Express were measured through 525∕30-nm
band-pass, 575∕30-nm band-pass, and 610-nm long-pass filters,
respectively. Viability was gated on the basis of side scatter
and electronic volume, and only viable cells were included in
fluorescence measurements. For samples expressing constructs
derived from pIL2, viable cells were further gated for dsRed-Ex-
press expression, which served as a transfection efficiency control,
before EGFP intensity values were collected. All fluorescence
measurements were reported as the geometric mean intensity ob-
served in the gated population. To control for toxicity and other
possible nonspecific effects of transfection and input ligand
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molecules, cells transfected with an inactive (scrambled) ham-
merhead ribozyme and treated with the corresponding concentra-
tion of ligand molecule served as positive controls to which values
from cells transfected with active ribozyme switches were normal-
ized. The inactive ribozyme constructs provide controls for the
maximum possible gene expression levels from the ribozyme-
based regulatory systems. CD19 antibody staining was performed
by washing 1 × 106 cells twice with 500 μL HBSS (Gibco), incu-
bating with 10 μL PE-conjugated CD19 antibody (Beckman Coul-
ter) in 50 μL HBSS for 15 minutes at 4 °C in the dark, washing
twice with 500 μL HBSS, and analyzing on the flow cytometer.
Transient transfection experiments were performed with at least
two replicate samples, and reported error bars indicate 1 standard
deviation from the averaged measured value normalized by the
inactive ribozyme control.
Stable CTLL-2 cell line generation. To generate a CTLL-2 cell line
for in vivo imaging, CTLL-2 cells were electroporated with the
pffLuc:zeo plasmid, and stable integrants were selected on the
basis of resistance to 0.1 mg∕mL zeocin. The stable cell line
CffLuc was confirmed through a luciferase activity assay, in which
1 × 104 cells were resuspended in 100 μL media and aliquoted
into 96-well black, clear-bottom plates. Each well was incubated
with 20 μL of 1.4 mg∕mL D-luciferin diluted in PBS (Xenogen)
at 37 °C for 10 minutes, and luciferase signal was detected by
using a Victor3 1420 Multilabel Counter (Perkin Elmer). Signals
from six replicates were averaged for each experiment, and
CTLL-2 cells not expressing ffluc were used as negative controls.
To generate CTLL-2 cells stably expressing constructs encod-
ing the T-cell proliferation regulatory system for in vivo imaging,
CffLuc cells were electroporated with plasmids derived from the
pIL15 plasmid and linearized at the unique NsiI site. Electro-
porations for stable cell lines were carried out in seven cuvettes,
each containing 5 × 106 cells and 5 μg plasmid DNA. One hour
after electroporation, all electroporated samples were combined,
diluted to a total volume of 50 mL, and supplemented with IL-2
every 48 hours to a final concentration of 100 U∕mL. Cells were
stained with PE-conjugated CD19 antibodies 7 days after electro-
poration and sorted for PEþ cells by FACS by using a BD FAC-
SAria cell sorter (BD Biosciences) equipped with a 488-nm laser.
The sorted cells were grown for 13 days and then stained and
further sorted via magnetism-automated cell sorting (MACS)
by using an autoMACS Separator (Miltenyi Biotec) for PEþ
cells. Theophylline was added to cell cultures to a final concen-
tration of 250 μM 2 days prior to each sort.
Following the FACS and MACS sorts, a series of selection
cycles were performed by alternating between growth in ganciclo-
vir and theophylline. Cells were grown for 2 weeks following auto-
MACS sorting in media supplemented with IL-2 every 48 hours
to a final concentration of 100 U∕mL. The cells were then grown
for 7 days in the presence of 1 μM ganciclovir and supplemented
with IL-2 every 48 hours to a final concentration of 100 U∕mL.
The cells were subsequently placed in fresh media supplemented
with 250 μM theophylline and allowed to grow for 4 days in the
absence of IL-2. Following termination of theophylline treat-
ment, the cells were placed in fresh media supplemented with
100 U∕mL IL-2 (added every 48 hours) and 5 μM ganciclovir
for 4 days. The theophylline treatment regime then resumed
for 8 days, followed by the ganciclovir treatment regime (at
5 μM) for 10 days and a final theophylline regime for 5 days.
Cell density was maintained between 0.05 × 106 and 0.5×
106 cells∕mL throughout the cell culture procedure. Following
the last theophylline treatment regime, cells were stained with
PE-conjugated CD19 antibodies and sorted for single clones into
96-well plates by FACS for low, medium, and high PE levels. The
sorted clones (CffLuc-pIL15) were grown in media supplemented
with 250 μM theophylline, 50 U∕mL penicillin:streptomycin, and
no IL-2. Clones were expanded from the low PE fractions into
larger culture volumes and finally maintained in T75 tissue
culture flasks (BD Falcon).
In vitro growth assay for stable CTLL-2 cell lines.CffLuc-pIL15 clones
were cultured under regular conditions (RPMI 1640 media sup-
plemented with 100 U∕mL IL-2 every 48 hours, 0.2 mg∕mL zeo-
cin, no theophylline), washed twice with HBSS, and split into five
identical aliquots in 6-well plates at approximately 0.01 ×
106 cells∕mL (4 mL∕well). Each well was supplemented with
one of the following: 100 U∕mL IL-2, 100 μM theophylline,
250 μM theophylline, 400 μM theophylline, or no IL-2 and no
theophylline. Cells were split and passaged as necessary into
new 6-well plates at approximately 0.03 × 106 cells∕mL, and
IL-2 was added to the appropriate wells to a final concentration
of 100 U∕mL every 48 hours. Cell count was obtained from 50 μL
of each culture daily for 7 days on a Quanta Cell Lab Flow Cyt-
ometer by gating for viable cells on the basis of side scatter and
electronic volume. Cell density was calculated by dividing the
number of detected live cells by the volume analyzed on the flow
cytometer.
CTLL-2 time-course study. CTLL-2 parental cells, clonal stable cell
line 1264-48 [L2bulge9(3×)], and clonal stable cell line 1266-3
(inactive ribozyme) were cultured under regular conditions.
On day 0, cells were counted for density and washed twice with
HBSS. Each cell line was used to seed two 50-mL cultures at
0.15 × 106 cells∕mL (set 1) and two 50-mL cultures at 0.05 ×
106 cells∕mL (set 2). One flask at each seeding density was trea-
ted with 500 μM theophylline. Set 1 flasks and set 2 flasks were
supplemented with 50 and 100 U∕mL IL-2, respectively, to keep
IL-2 concentration consistent with seeding cell density and har-
vesting schedule. On day 1, set 1 flasks were harvested for CD19
antibody staining (1 × 106 cells per sample) and for cell pellet col-
lection for qRT-PCR (12.5 × 106 cells per sample, washed once
with HBSS, and flash frozen with liquid nitrogen). Each culture
was split to 0.05 × 106 cells∕mL at 50 mL total and supplemented
with 100 U∕mL IL-2 and the appropriate concentration of theo-
phylline (0 or 500 μM). On day 2, the same harvest and subculture
procedures were repeated for set 2 flasks. All cultures were trea-
ted in this manner every 48 hours until day 7. On day 7, the cell
count was obtained for all cultures. After harvesting from set 1
flasks, all cultures were washed twice with HBSS and resus-
pended in fresh media without theophylline. Set 1 flasks were
seeded a t 0.05 × 106 cells∕mL and supp lemented w i th
100 U∕mL IL-2. Set 2 flasks were seeded with all available cells
and supplemented with 50 U∕mL IL-2. On days 8 and 9, the
same harvest and subculture procedures were performed on
set 2 and set 1 flasks, respectively. All cultures were treated in
this manner every 48 hours until day 14. On day 14, the cell count
was obtained for all cultures. After harvesting from set 2 flasks, all
cultures were washed twice with HBSS and resuspended in fresh
media. All cultures that had been treated with theophylline on
days 0–7 were supplemented with 500 μM theophylline on day
14. Set 2 flasks were seeded at 0.05 × 106 cells∕mL and supple-
mented with 100 U∕mL IL-2. Set 1 flasks were seeded with all
available cells and supplemented with 50 U∕mL IL-2. On days
15 and 16, samples were harvested for CD19 staining and subcul-
tured as before for set 2 and set 1 flasks, respectively. All cultures
were treated in this manner every 48 hours until day 18.
Transcript analysis through qRT-PCR. mRNA was purified from fro-
zen cell pellets with the GenElute Direct mRNA MiniPrep Kit
(Sigma) following the manufacturer’s protocols. mRNA samples
were treated with 100 U∕mL DNaseI at 37 °C for 15 minutes and
purified by phenol-chloroform extraction and ethanol precipita-
tion. Reverse transcription was performed with 300 ng mRNA,
2 pmol of each primer, 10 nmol dNTP, 40 U RNaseOUT,
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5 mM DTT, 1× First-Strand Buffer, and 200 U SuperScript III
Reverse Transcriptase (Invitrogen) in a 20 μL reaction following
the manufacturer’s protocols. Gene-specific primers (Hprt1
reverse, 5′TGCTGCCATTGTCGAACA; IL -15 reverse,
5′GGTGTCGTGGATGCTG) were used in the cDNA synthesis
reactions. The resulting cDNA samples were subsequently trea-
ted with 2.5 U of RNaseH at 37 °C for 20 minutes, followed by
heat inactivation at 65 °C for 20 minutes.
qRT-PCR reactions were performed in a 25 μL reaction with
200 nM of each primer, 5 μL cDNA, and 1× SYBR Green Super-
Mix (Bio-Rad) on an iCycler Real-Time PCRmachine (Bio-Rad).
Separate reactions were performed for the housekeeping gene
Hprt1 (Hprt1 forward, 5′AGCCAGCGAAGCCAC; Hprt1 re-
verse) and the target gene il-15 (IL-15 forward, 5′CAACTGGGT-
GAACGTGAT; IL-15 reverse). The qRT-PCR protocol included
32 cycles of a 15-second annealing step at 50 °C and a 30-second
extension step at 72 °C, followed by a melt curve analysis to verify
absence of nonspecific products. All reactions were performed in
triplicate, and threshold cycle (Ct) values were averaged to obtain
the arithmetic mean. Relative IL-15 expression levels were cal-
culated with the following formula (2):
RE ¼ ε
ðCt;Hprt1Þ
Hprt1
ε
ðCt;IL-15Þ
IL-15
;
where RE indicates relative IL-15 expression, εx indicates prim-
er efficiency for gene x, and Ct;x indicates the averaged Ct value
for gene x. Standard deviation was calculated with the following
formula:
STD ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
½RE lnðεHprt1Þ2ðStdHprt1Þ2 þ ½RE lnðεIL-15Þ2ðStdIL-15Þ2
q
;
where STD indicates standard deviation in relative IL-15 expres-
sion and Stdx indicates standard deviation calculated from the
triplicate samples for gene x. Reported error bars indicate 1 stan-
dard deviation.
Western blot analysis of STAT5 levels. Clonal stable cell lines were
cultured under regular conditions (see above), washed twice with
HBSS, and split into two identical aliquots. The aliquots were
grown in the absence of IL-2 and either in the presence or ab-
sence of 500 μM theophylline for 3 days. Approximately 2 ×
106 cells of each sample were harvested and washed with
1 mL HBSS each day, frozen with liquid nitrogen, and stored
at −80 °C until lysis. Cell pellets were lysed with 50 μL Triton-
X lysis buffer (1% Triton-X, 10 mM Tris-HCl, pH 7.4,
130 mMNaCl, 5 mM EDTA, protease inhibitor, 5% phosphatase
inhibitor cocktail II) and incubated on ice for 1 hour. Lysates
were centrifuged at 14; 000 × g for 20 minutes at 4 °C. The super-
natant was collected and immediately frozen at −80 °C.
Lysate samples were thawed on ice and a standard Bradford
assay using Protein Assay Dye (Bio-Rad) was performed with
a BSA standard to determine protein concentrations. Samples
were run on NuPAGE 4–12% Bis-Tris Gels (Invitrogen) at
90 V for 2.5 hours, where 50 μg of protein from each sample
was loaded. Blotting was performed with Mini Trans-Blot Filter
Paper (Bio-Rad) and 0.45 μm Nitrocellulose Membranes (Bio-
Rad) wetted with NuPAGE transfer buffer (Invitrogen) and
transferred at 40 mA per gel with a Hoefer Semi-Phor Blotter
(Hoefer Scientific Instruments). Membranes were blocked with
Odyssey Blocking Buffer (Li-Cor) at 4 °C for 1 hour and probed
with Rabbit-anti-pSTAT5 antibody (Cell Signaling) or IRDye
800CW-conjugated anti-β-actin antibody (Rockland) at 4 °C over-
night in the dark. Membranes probed with p-STAT5 antibodies
were washed 4 times with 100 mL TTBS (1× TBS; Bio-RAD),
0.1% Tween 20 (Sigma), and further stained with IRDye
800CW-conjugated goat-anti-rabbit antibody (Li-Cor) at room
temperature for 1 hour. Membranes stained for β-actin and p-
STAT5 were washed 4 times with 100 mL TTBS and once with
100 mL TBS before fluorescent images were acquired and quan-
tified with the Odyssey Infrared Imaging System (Li-Cor). Inte-
grated band intensity was calculated with the Odyssey system by
using blank gel areas surrounding each band for background sub-
traction. Relative p-STAT5 expression levels were calculated by
normalizing the integrated intensity of the p-STAT5 band by that
of the β-actin band from the same protein sample. Data shown
are representative of two independent experiments.
In vivo T-cell proliferation studies in NOD/SCID-IL2(ko) mice. Various
CffLuc-pIL15 cell lines, CffLuc, and a CffLuc-derived cell line
stably expressing a cytokine fusion transgene with an inactive ri-
bozyme in the 3′ UTRof the transgene were expanded under reg-
ular culture conditions. Cells were harvested by centrifugation at
1,200 rpm at 4 °C for 10 minutes, washed twice with PBS, resus-
pended in PBS at a concentration of 2 × 106 cells∕mL, and split
into two 50-μL aliquots. Each aliquot was mixed with 50 μL of
either PBS or 2 mM theophylline dissolved in PBS. The 100-μL
cell suspension was then mixed with 100 μL of Matrigel (BD Bio-
sciences), for a total of 0.1 × 106 cells at a final concentration of 0
or 500 μM theophylline. The cell suspensions were injected sub-
cutaneously (s.c.) into the right or left flank of NOD/scid-IL2(ko)
mice. All mice were 8–10 weeks old and bred in the City of Hope
lab animal breeding facility, and experiment protocols were ap-
proved by the City of Hope Institute Animal Care and Use Com-
mittee. In vivo growth of the injected cells was monitored by
biophotonic imaging. Clone 1264-48 and the positive control cell
line expressing an inactive ribozyme were tested in a second ex-
periment following the procedure described above. Each cell line
was injected into both flanks of three mice either with or without
500 μM theophylline, generating six replicates for each experi-
mental condition. One of the mice injected with clone 1264-48
without theophylline exhibited abnormally large engraftments
in both flanks. Additional subjects were studied to verify that cell
growth in this mouse was aberrant in a statistically significant
manner (P ¼ 0.044 on the basis of comparison against eight other
replicates with the same experimental condition), and data from
this mouse were excluded from statistical analyses of the ribo-
zyme switch system.
Biophotonic in vivo imaging.Animals received intraperitoneal (i.p.)
injections of 4.29 mg per mouse of freshly prepared luciferin
substrate (Caliper Life Sciences) suspended in 150 μL of PBS.
Mice were then anesthetized with isoflurane (1.5 L oxygenþ
4% isoflurane per minute) in an induction chamber. After induc-
tion of deep anesthesia, mice were imaged by using the IVIS Im-
aging System 100 Series (Xenogen) consisting of a CCD camera
mounted on a light-tight specimen chamber (darkbox), a camera
controller, a camera cooling system, and a Windows computer
system for data acquisition and analysis. Images were acquired
at 10–20 minutes after luciferin injection with the appropriate ex-
posure time and binning mode to prevent signal saturation. Lu-
ciferase activity was analyzed through Living Image Software 3.1
from Xenogen to quantify tumor region flux (photons per
second).
Statistical analysis. Statistical analysis was performed on growth
rate data by using the Mann–Whitney U test to calculate two-
tailed P values. The doubling time of injected cells was calculated
on the basis of the total luciferase signal flux data collected over
the course of each in vivo study. Signal flux data were fitted to an
exponential curve, and the resulting equation was used to calcu-
late cell-doubling time by using the equation:
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tD ¼ ðt2 − t1Þ
logð2Þ
logðF2 − F1Þ
;
where t is time, F is signal flux, and tD is doubling time.
Lentivirus production. HEK 293T cells were seeded at 5.0 × 106
cells in 9 mL per 10-cm tissue culture plate and transfected with
1 mL solution containing vector DNA, 62 mM CaCl2, and 1×
Hepes buffered saline. Cells were washed twice with 5 mL 1×
PBS without magnesium and calcium the following morning
and fed 10 mL of complete DMEMwith 60 mM sodium butyrate.
At 24, 48, and 72 hours posttransfection, viral supernatants were
harvested by centrifugation at 2,000 rpm for 10 minutes at 4 °C
and filtered through a 0.45-μM vacuum filtration unit. Viral
supernatants from all time points were pooled and mixed with
¼ volume of 40% PEG. After rotating overnight at 4 °C, samples
were centrifuged at 3,000 rpm for 20 minutes at 4 °C and the
supernatants discarded. Pellets were resuspended in 35 mL ser-
um-free DMEM and ultracentrifuged at 24,500 rpm for 1.5 hours
at 4 °C. Resulting pellets were resuspended in 50 μL serum-free
FBS and vortexed at 4 °C for 2 hours. Then 10% FBS was added
and the samples stored at −80 °C until titering and use.
Derivation of central memory T (TCM) cells from human peripheral
blood mononuclear cells (PBMCs).PBMCs were isolated from donor
apheresis products, and 5 × 108 cells were washed twice with
35 mL MACS buffer (2 mM EDTA and 0.5% BSA in PBS)
and resuspended in 1.5 mL MACS buffer. Washed cells were
stained with 0.75 mL each of CD4, CD14, and CD45RAmicrobe-
ads (Miltenyi Biotec) and depleted for CD4, CD14, and CD45RA
by using an autoMACS Separator (Miltenyi). Depleted cells were
washed once with 35 mL MACS buffer, resuspended in 3.5 mL
MACS buffer with 10.5 μL anti-CD62L DREG56-biotin antibody
(City of Hope Center for Biomedicine and Genetics), and incu-
bated for 20 minutes in the dark at 4 °C. Cells were washed twice
with 35 mLMACS buffer and resuspended in 1.2 mL MACS buf-
fer with 300 μL antibiotin microbeads (Miltenyi). Cells were en-
riched for CD62L by using an autoMACS Separator, placed in
fresh RPMI 1640 media supplemented with 10% FBS and stored
in a 37 °C incubator.
Lentiviral transduction of TCM cells. TCM cells were seeded at 0.5 ×
106 cells in 500 μL per well in a 48-well plate. One and a half
million anti-CD3/anti-CD28 Dynabeads (Invitrogen) were
washed with 1% heat-inactivated human serum in PBS (pH
7.4), resuspended in 500 μLT-cell media (RPMI 1640 supplemen-
ted with 10% heat-inactivated fetal bovine serum) containing
0.5 × 106 TCM cells, and added to each of two wells in a 48-well
plate. Each well was fed with 50 U∕mL IL-2 and 0.5 ng∕mL IL-
15, infected with viruses at a multiplicity of infection of 5, and
treated with protamine sulfate at a final concentration of
5 μg∕mL. The plate was centrifuged at 2,100 rpm for 30 minutes
at 32 °C and incubated at 37 °C for 4 hours. Each well was sup-
plemented with 500 μL of warm T-cell media, and the plate was
incubated at 37 °C. Cells were assayed by flow cytometry on day 8
posttransduction and Dynabeads were removed on day 14 post-
transduction.
TCM cell time-course study. TCM cells transduced with the cd19-t2a-
il15-L2bulge9(3×) or cd19-t2a-il15-inactive ribozyme constructs
were stimulated with 100 × 106 PBMCs, 10 × 106 TM-LCLs,
and 30 ng∕mL OKT2 for each T75 flask and cultured under reg-
ular conditions for 12 days. On day 12 poststimulation, each cell
line was washed twice with HBSS and used to seed 25-mL cul-
tures at 0.45 × 106 cells∕mL. Cell media were supplemented with
either no theophylline or 500 μM theophylline, and no IL-2 or
IL-15 was added. The CD19 expression level study was per-
formed with duplicate cultures, and the apoptosis staining study
was performed with triplicate cultures. Each culture was sampled
every 24 hours for antibody staining with PE-conjugated CD19
antibody (Beckman Coulter). For the apoptosis study, CD19-
stained samples where subsequently stained with Pacific Blue-
conjugated annexin Vand SYTOXAAD dead cell stain (Invitro-
gen) following manufacturer’s protocols. Fluorescence data were
obtained by using a Quanta Cell Lab Flow Cytometer (Beckman
Coulter) with both a 488-nm laser and an UV arc lamp. Pacific
Blue, PE, and SYTOX AAD were detected through 465∕30-nm
band-pass, 575∕30-nm band-pass, and 610-nm long-pass filters,
respectively. The percent CD19 expression was calculated by
measuring the PE expression level of PEþ gated cells and nor-
malizing results of the L2bulge9(3×) sample by those of the in-
active ribozyme sample cultured at the same theophylline
concentration. Only SYTOX AAD- cells were included in data
analyses for the apoptosis study. The population of live
CD19þ cells was determined by gating for annexin V−∕PEþ
cells, and the population of apoptotic CD19þ cells was deter-
mined by gating for annexin Vþ∕PEþ cells. Relative population
distribution was calculated by normalizing results of the L2bulge9
(3×) sample to those of the inactive ribozyme sample cultured at
the same theophylline concentration.
T2A sequences.
T2A DNA sequence.
GGCAGCGGAGAGGGCAGAGGAAGTCTTCTAACATGC-
GGTGACGTGGAGGAGAATCCCGG
T2A peptide sequence.
GSGEGRGSLLTCGDVEENPG
Ribozyme switch sequences. Italicized, spacer sequences; under-
lined, restriction sites.
sTRSV hammerhead ribozyme.
5′CTCGAG AAACAAACAAA GCTGTCACCGGATGTGCTT-
TCCGGTCTGATGAGT CCGTGAGGACGAAACAGC AAA-
AAGAAAAATAAAAATTTTTTGGAA TCTAGA
L2bulge1.
5′CTCGAG GCGATCGC AAACAAACAAA GCTGTCACCG-
GATGTGCTTTCCGGTCTGATGAGTCCGTGTCCATACCA-
GCATCGTCTTGATGCCCTTGGCAGGGACGGGACGAG-
GACGAAACAGC AAAAAGAAAAATAAAAATTTTTTTT TT-
AATTAA TCTT GGGCCC
L2bulge8.
5′CTCGAG GCGATCGC AAACAAACAAA GCTGTCACCG-
GATGTGCTTTCCGGTCTGATGAGTCCGTTGTCCATACC-
AGCATCGTCTTGATGCCCTTGGCAGGGACGGGACGG-
AGGACGAAACAGC AAAAAGAAAAATAAAAATTTTTTTT
TTAATTAA TCTT GGGCCC
L2bulge9.
5′CTCGAG GCGATCGC AAACAAACAAA GCTGTCACCG-
GATGTGCTTTCCGGTCTGATGAGTCCGTTGTCCAATAC-
CAGCATCGTCTTGATGCCCTTGGCAGTGGATGGGGAC-
GGAGGACGAAACAGC AAAAAGAAAAATAAAAATTTTT-
TTT TTAATTAA TCTT GGGCCC
L2bulge18tc.
5′CTCGAG GCGATCGC AAACAAACAAA GCTGTCACCG-
GATGTGCTTTCCGGTCTGATGAGTCCGTTGTCCAAAAC-
ATACCAGATTTCGATCTGGAGAGGTGAAGAATTCGAC-
CACCTGGACGAGGACGGAGGACGAAACAGCAAAAAGA-
AAAATAAAAA TTAATTAA TCTT GGGCCC
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Inactive ribozyme.
5′CTCGAG GCGATCGC AAACAAACAAA GCTGTCACCG-
GATGTGCTTTCCGGTACGTGAGGTCCGTGAGGACAGA-
ACAGC AAAAAGAAAAATAAAAATTTTTTTT TTAATTAA
TCTT GGGCCC
Controlling for toxicity and nonspecific effects of nucleofection and
small-molecule ligand inputs on growth and gene expression. Gene
expression can be sensitive to a myriad of external factors, and
accurate characterization of phenotypic responses, such as cell
growth and viability, requires appropriate controls to account
for potential nonspecific effects of experimental procedures ap-
plied to the cells. In particular, the toxicity and other nonspecific
effects of transfection and small-molecule ligand addition were
of concern in the characterization of the ligand-responsive,
ribozyme-based regulatory systems described here. Careful con-
trols were included in the experiments reported in this study to
ensure accurate accounting of any potential nonspecific effects.
Like most T-cell lines, CTLL-2 cells cannot be effectively
transfected by lipid-based transfection reagents. Therefore,
electroporation with Amaxa Nucleofector technology is the
method of choice for transfecting CTLL-2 cells. The trauma of
nucleofection results in high cell mortality and affects the health
of surviving cells. To account for the toxicity of nucleofection, all
experiments conducted in this study included as a positive control
cells nucleofected with a similar DNA construct harboring an in-
active, scrambled ribozyme that lacks an attached aptamer. This
control construct has no ribozyme-based knockdown activity and
no ligand-responsive cleavage activity, and it represents the max-
imum possible expression level from the regulatory system. Via-
bility and fluorescence data from all other samples were reported
relative to those of the positive control treated with the same
concentration of small-molecule ligand. It has been verified by
multiple nucleofection experiments that nucleofection toxicities
from similar DNA constructs purified in the identical manner
are similar.
The reproducible agreement between two characterization
methods—viability (a phenotypic response) and fluorescence
(a measure of reporter gene expression)—provided further con-
firmation of ligand-responsive gene regulatory activity (Fig. 2 and
Fig. S1). To verify that growth cytokine withdrawal (and not nu-
cleofection toxicity) is responsible for the decrease in viability le-
vels observed for cells transfected with active ribozyme switch
constructs, transfected samples were split into two identical ali-
quots, one of which was fed with 100 U∕mL of exogenous IL-2, a
concentration that is sufficient to sustain healthy expansion of
CTLL-2 cells during routine culture maintenance. The IL-2-
treated samples had significantly higher viability levels compared
to identical samples not treated with exogenous IL-2 (Fig. S9A).
Furthermore, the inverse correlation between viability and ribo-
zyme switch copy number disappears in the presence of exogen-
ous IL-2, suggesting that the reduced viability at high switch copy
numbers is specifically caused by more efficient gene expression
knockdown and the resultant cytokine withdrawal in the absence
of exogenous IL-2. In contrast, the addition of exogenous IL-2
does not affect fluorescence levels (Fig. S9B). Taken together,
these results indicate that the observed variations in viability le-
vels are specific to the regulatory systems.
The toxicity and potential pleiotropic effects of the small-
molecule ligands theophylline and tetracycline were also consid-
ered. In transient transfection experiments the fluorescence and
viability values of all samples were normalized to that of the in-
active ribozyme control treated with the same concentration of
the small-molecule ligand (as described above) to account for
non-aptamer-mediated effects of the ligand, as it is assumed that
the nonspecific effects of the ligand will be similar for the sample
and the control. Negative controls, such as cells transfected with
vectors that encode either no growth cytokine or a growth cyto-
kine gene coupled to a fully active, nonswitch hammerhead ribo-
zyme control (sTRSV), were included in all transient transfection
experiments. The relative viability and fluorescence levels from
the negative control samples exhibited no response to ligand
addition, indicating that the normalization method adequately
accounts for the toxicity and pleiotropic effects of the small-
molecule ligands (Fig. 2B and Fig. S1A).
By using the inactive ribozyme as the normalizing control for
all switch constructs in all transient transfection studies, we report
the regulatory output of the switches relative to the maximum
possible expression range. Compared to the more commonly used
method of internal normalization, where each switch construct is
normalized to its own internal high value, our method has the
effect of reducing the apparent dynamic range of each switch.
However, the reporting of switch output to a consistent standard
control allows for direct and accurate comparison of the various
switches, which is important for system development and charac-
terization. The internal normalization method is employed for in
vitro gene expression assays on stably integrated cell lines
(Figs. 3B and 5 and Fig. S5A), because the maximum expression
level of each clone is dependent on the integration site, which
varies from clone to clone.
In the characterization of cell lines stably expressing the ribo-
zyme switch constructs, a clonal cell line expressing the positive
control construct (inactive ribozyme) was included to identify any
nonspecific effects of theophylline. As an example, an in vitro
growth assay was performed on clonal cell lines in the presence
or absence of 500 μM theophylline. The cell line expressing the
inactive ribozyme exhibited a decreased growth rate in the pre-
sence of theophylline (Fig. S9C), indicating theophylline toxicity
and verifying that the theophylline-induced increase in absolute
growth rate observed from clones expressing the active ribozyme
switches were not because of any nonspecific growth-stimulatory
effects of theophylline (Fig. 3A and Fig. S4). As another example,
positive and negative control cell lines were included in the ani-
mal studies and no significant theophylline-dependent differ-
ences were observed in the in vivo growth pattern of cells that
either do not express growth cytokines or express the inactive ri-
bozyme control (Fig. 4A and Fig. S6C). In contrast, the in vitro
and in vivo growth rates of clonal cell lines expressing functional
ribozyme switch systems show increases in absolute growth rate
(not normalized to the inactive ribozyme control) in response to
theophylline addition (Figs. 3A and 4B and Figs. S4 and S7). Ta-
ken together, these results indicate that the observed T-cell
growth behaviors were specific to the ligand-responsive regula-
tory system.
1. Sambrook J, Russell DW (2001) Molecular Cloning: A Laboratory Manual (Cold Spring
Harbor Press, Plainview, NY) 3rd Ed.
2. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-
time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408.
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Fig. S1. Tunable, small-molecule-mediated regulation of gene expression in mammalian cells by ribozyme switches. (A) GFP expression levels are reported for
constructs encoding theophylline-responsive switches (L2bulge1, 8, 9) in one (1×), two (2×), three (3×), and four (4×) copies through transient transfections in
CTLL-2 cells grown in 0 and 1 mM theophylline. No IL-2 control, construct not encoding a proliferative cytokine; sTRSV Ribozyme, construct encoding a non-
switch hammerhead ribozyme. (B) GFP expression levels are reported for multiple-copy L2bulge9 regulatory systems at various theophylline concentrations.
Fluorescence values were normalized as described in Fig. 2. Values are mean SD from at least two replicate samples. Fluorescence and viability measurements
yielded consistent results, thus validating the use of a fusion transgene as the regulatory target.
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Fig. S2. Stable cell lines expressing multiple ribozyme switches exhibit lowered basal level and increased switch dynamic range. Stable integrants were se-
lected by fluorescence-based cell sorting for CD19þ populations. Bulk-sorted cells were cultured either with or without 250 μM theophylline for 6 days and
CD19 expression levels were monitored by staining with PE-conjugated CD19 antibodies. Although bulk cell lines stably expressing the single-copy ribozyme
switch system did not exhibit significant increases in gene expression in response to 250 μM theophylline, individual clones that exhibited low basal expression
levels and significant theophylline-responsive increases in expression were successfully isolated from this bulk population (see Fig. S4).
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Fig. S3. The generation of T-cell lines stably expressing the ribozyme switch systems through alternate cycles of negative and positive selections. CTLL-2 cells
stably expressing a luciferase reporter (CffLuc) were transfected with linearized plasmids encoding ribozyme switch systems on the basis of L2bulge9. Stable
integrants were initially sorted for CD19 expression and subsequently subjected to alternate cycles of negative and positive growth selection with ganciclovir
and theophylline, respectively. Gene expression levels were monitored by staining with PE-conjugated CD19 antibody; blue, bulk stable cd19-tk-t2a-il15-
L2bulge9(3×) cell line; red, CffLuc cell line.
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Fig. S4. Clonal CTLL-2 cell lines stably expressing engineered ribozyme switch systems exhibit effective theophylline-responsive growth regulation. The cell
lines were cultured at various theophylline concentrations, and cell growthwasmonitored by counting viable cells. Clones indicated as 1261-xx stably expressed
cd19-tk-il15-L2bulge9(1×). Clone 1264-xx stably expressed cd19-tk-il15-L2bulge9(3×). Growth behaviors differ from clone to clone, as would be expected from
non-site-specific integration of the transgene into the host chromosomes. Theophylline-responsive increase in cell growth is evident in 15 of the 16 tested
clones, and the growth elevation is statistically significant for the sample set (P ¼ 0.0150, 0.0011, and 0.0013 for 100, 250, and 400 μM, respectively, byWhitney–
Mann U test).
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Fig. S5. Cells stably expressing the T-cell proliferation regulatory system exhibit theophylline-responsive increase in IL-15 transcription and signal transduction
through the JAK-STAT pathway. (A) Relative IL-15 mRNA levels are elevated in the presence of theophylline and return to basal levels upon theophylline
removal. qRT-PCR was performed on mRNA extracted from a CTLL-2 cell line stably expressing cd19-tk-il15-L2bulge9(3×) (clone 1264-48). IL-15 expression
levels were normalized to expression levels of the housekeeping gene hprt1, and relative IL-15 expression levels were obtained by normalizing to the inactive
ribozyme control. The highest expression level was set to 100%. Reported values are mean SD from three replicate samples. Samples shown in this figure
were collected from the same cultures as described in Fig. 3B. The red dashed line indicates background signal from a cell line without a CD19 expression
construct. (B) Western blot analysis was performed on protein extracts from the CffLuc and 1264-48 cell lines for phosphorylated STAT5 (p-STAT5), an inter-
mediate in the IL-15 signaling cascade. The levels of p-STAT5 in each sample were normalized to that of β-actin. The 1264-48 cell line, which stably expresses
cd19-tk-il15-L2bulge9(3×), showed increased p-STAT levels in response to theophylline, indicating an increase in IL-15 signaling. The CffLuc cell line, which lacks
the ribozyme switch system, served as a negative control and verified that theophylline did not nonspecifically activate the JAK-STAT pathway. The CffLuc cell
line could not survive beyond 2 days without exogenous IL-2, further demonstrating that the autocrine growth cytokine production is necessary for sustaining
CTLL-2 survival and proliferation in the absence of exogenous cytokine supplies.
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Fig. S6. Clonal cell line 1264-48 exhibits accelerated T-cell proliferation in response to small-molecule input. (A) Total luciferase signal flux measurements
collected over a 14-day period were fitted to an exponential curve and used to calculate the in vivo growth rate of the injected cells. (B) Images of clone 1264-48
over time. The day of imaging postinjection of the stable cell line is indicated. (C) The ribozyme switch system demonstrates robust and reproducible small-
molecule-mediated control over T-cell proliferation in vivo. Images are shown for day 4 postinjection of the positive control and clone 1264-48. Identical clones
were injected into the two flanks of each mouse in the presence or absence of 500 μM theo.
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Fig. S7. A clonal cell line stably expressing a functional ribozyme-based regulatory system exhibits theophylline-responsive increases in the in vivo growth
rate. Total luciferase signal fluxmeasurements collected over a 9-day period from replicatemice were fitted to an exponential curve and used to calculate the in
vivo growth rate of the injected cells. (A and B) Clone 1264-48 injected in the absence (A) or presence (B) of 500 μM theophylline. (C and D) Inactive ribozyme
control cells injected in the absence (C) or presence (D) of 500 μM theophylline. Results indicate a 40% increase in the growth rate of clone 1264-48 in response
to 500 μM theophylline and no statistically significant difference in the growth rate of the inactive ribozyme control in the presence and absence of
theophylline.
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Fig. S8. Plasmid maps of T-cell proliferation constructs. (A) pffLuc:zeo was used in constructing T-cell lines stably expressing firefly luciferase for in vivo ima-
ging; (B and C) pIL2 and pIL15 are the base T-cell proliferation expression constructs into which the ribozyme-based regulatory devices are inserted.
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Fig. S9. Appropriate controls demonstrate observed ligand-responsive switch activities are because of specific effects of cytokine withdrawal. (A) Relative
viability of CTLL-2 cells transiently transfectedwith ribozyme-based regulatory systems as measured by flow cytometry. The presence of exogenous IL-2 elevates
viability in all samples and abolishes the inverse correlation between viability and ribozyme switch copy number observed in the absence of exogenous IL-2.
These results suggests that the reduced viability at high switch copy numbers observed in the absence of exogenous IL-2 is specifically caused by more efficient
knockdown of the cytokine transgene encoded by the regulatory system and the resultant cytokine withdrawal. (B) GFP expression in CTLL-2 cells transiently
transfected with ribozyme-based regulatory systems. Fluorescence values were normalized as described in Fig. 2. The samples shown here correspond to those
shown inA. In contrast to viability behaviors shown in A, switch activity as measured by fluorescence is unaffected by the presence of exogenous IL-2, indicating
that the gene expression modulation is specific to the regulatory system. (C) Theophylline inhibits growth in CTLL-2 cells. CffLuc cells and a clonal cell line stably
expressing the inactive ribozymewere cultured in the presence or absence of 500 μM theophylline without exogenous IL-2. Cell count was monitored for 9 days
by flow cytometry. CffLuc cells failed to expand because of lack of growth cytokines. The inactive ribozyme control, which expresses high levels of cytokine
independent of theophylline, showed reduced growth in the presence of theophylline, indicating theophylline toxicity.
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